{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:15:51Z","timestamp":1783102551204,"version":"3.54.6"},"reference-count":67,"publisher":"Associa\u00e7\u00e3o de Medicina Intensiva Brasileira","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"DOI":"10.62675\/2965-2774.20260353","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:23:52Z","timestamp":1783099432000},"source":"Crossref","is-referenced-by-count":0,"title":["Perioperative albumin versus other fluids to prevent cardiac surgery-associated kidney injury: a systematic review and meta-analysis of randomized trials"],"prefix":"10.62675","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8396-3882","authenticated-orcid":false,"given":"Phoebe R","family":"Darlison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4707-7462","authenticated-orcid":false,"given":"Yahya","family":"Shehabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3502-2288","authenticated-orcid":false,"given":"Humphrey G. M.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1520-9387","authenticated-orcid":false,"suffix":"Neto","given":"Ary","family":"Serpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6858-5522","authenticated-orcid":false,"given":"David C.","family":"Motorniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0527-5348","authenticated-orcid":false,"given":"Adrian","family":"Pakavakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7071-4031","authenticated-orcid":false,"given":"Mayurathan","family":"Balachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0989-5640","authenticated-orcid":false,"given":"Geoffrey J.","family":"Wigmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1650-8939","authenticated-orcid":false,"given":"Rinaldo","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3137-4895","authenticated-orcid":false,"given":"Alastair J. W.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"49293","reference":[{"issue":"24","key":"key20260703172348_B1","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10245746","article-title":"CSA-AKI: incidence, epidemiology, clinical outcomes, and economic impact","volume":"10","author":"Schurle","year":"2021","unstructured":"1. Schurle A, Koyner JL. CSA-AKI: incidence, epidemiology, clinical outcomes, and economic impact. J Clin Med. 2021;10(24):5746.","journal-title":"J Clin Med"},{"issue":"1","key":"key20260703172348_B2","doi-asserted-by":"crossref","DOI":"10.1186\/s40001-023-00990-2","article-title":"Diagnosis, pathophysiology and preventive strategies for cardiac surgery-associated acute kidney injury: a narrative review","volume":"28","author":"Yu","year":"2023","unstructured":"2. Yu Y, Li C, Zhu S, Jin L, Hu Y, Ling X, et al. Diagnosis, pathophysiology and preventive strategies for cardiac surgery-associated acute kidney injury: a narrative review. Eur J Med Res. 2023;28(1):45.","journal-title":"Eur J Med Res"},{"issue":"1","key":"key20260703172348_B3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.jvca.2015.07.013","article-title":"Long-term consequences of acute kidney injury after cardiac surgery: a systematic review and meta-analysis","volume":"30","author":"Corredor","year":"2016","unstructured":"3. Corredor C, Thomson R, Al-Subaie N. Long-term consequences of acute kidney injury after cardiac surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2016;30(1):69-75.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"4","key":"key20260703172348_B4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40620-016-0351-0","article-title":"The duration of acute kidney injury after cardiac surgery increases the risk of long-term chronic kidney disease","volume":"30","author":"Palomba","year":"2017","unstructured":"4. Palomba H, Castro I, Yu L, Burdmann EA. The duration of acute kidney injury after cardiac surgery increases the risk of long-term chronic kidney disease. J Nephrol. 2017;30(4):567-72.","journal-title":"J Nephrol"},{"issue":"1","key":"key20260703172348_B5","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"Kidney Disease Improving Global Outcomes (KDIGO)","year":"2012","unstructured":"5. Kidney Disease Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1-138.","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"key20260703172348_B6","first-page":"34","article-title":"Introduction of guidelines for the use of albumin and the effect on albumin prescribing practices in British Columbia","volume":"54","author":"King","year":"2012","unstructured":"6. King WS, Roland K, Selin S, Chipperfield K, Morrison D. Introduction of guidelines for the use of albumin and the effect on albumin prescribing practices in British Columbia. B C Med J. 2012;54(1):34-8.","journal-title":"B C Med J"},{"issue":"2","key":"key20260703172348_B7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/0018578718823727","article-title":"Evaluation of albumin 25% use in critically ill patients at a tertiary care medical center","volume":"55","author":"Torbic","year":"2020","unstructured":"7. Torbic H, Bauer SR, Militello M, Welch S, Udeh C, Richardson S. Evaluation of albumin 25% use in critically ill patients at a tertiary care medical center. Hosp Pharm. 2020;55(2):90-5.","journal-title":"Hosp Pharm"},{"issue":"10","key":"key20260703172348_B8","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1007\/s12630-021-02070-7","article-title":"Albumin use in bleeding cardiac surgical patients and associated patient outcomes","volume":"68","author":"Hanley","year":"2021","unstructured":"8. Hanley C, Callum J, McCluskey S, Karbouti K, Bartoszko J. Albumin use in bleeding cardiac surgical patients and associated patient outcomes. Can J Anaesth. 2021;68(10):1514-26.","journal-title":"Can J Anaesth"},{"issue":"7","key":"key20260703172348_B9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s12630-022-02237-w","article-title":"Albumin use for fluid resuscitation in cardiac surgical patients: a survey of Canadian perioperative care providers","volume":"69","author":"Liu","year":"2022","unstructured":"9. Liu L, McCluskey SA, Law M, Abrahamyan L, Peer M, Tait G. Albumin use for fluid resuscitation in cardiac surgical patients: a survey of Canadian perioperative care providers. Can J Anesth. 2022;69(7):818-31.","journal-title":"Can J Anesth"},{"issue":"15","key":"key20260703172348_B10","article-title":"Fluid resuscitation practices in cardiac surgery patients in the USA: a survey of health care providers","volume":"6","author":"Aronson","year":"2017","unstructured":"10. Aronson S, Nisbet P, Bunke M. Fluid resuscitation practices in cardiac surgery patients in the USA: a survey of health care providers. Perioper Med (Lond). 2017;6(15):15.","journal-title":"Perioper Med (Lond)"},{"issue":"3","key":"key20260703172348_B11","first-page":"164","article-title":"Intravenous fluid use after cardiac surgery: a multicentre, prospective, observational study","volume":"16","author":"Parke","year":"2014","unstructured":"11. Parke RL, McGuinness SP, Gilder E, McCarthy LW. Intravenous fluid use after cardiac surgery: a multicentre, prospective, observational study. Crit Care Resusc. 2014;16(3):164-9.","journal-title":"Crit Care Resusc"},{"issue":"5","key":"key20260703172348_B12","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1053\/j.jvca.2017.04.017","article-title":"Fluid Management in Cardiac Surgery: Results of a Survey in European Cardiac Anesthesia Departments","volume":"31","author":"Protsyk","year":"2017","unstructured":"12. Protsyk V, Rasmussen BS, Guarracino F, Erb J, Turton E, Ender J. Fluid Management in Cardiac Surgery: Results of a Survey in European Cardiac Anesthesia Departments. J Cardiothorac Vasc Anesth. 2017;31(5):1624-9.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"5","key":"key20260703172348_B13","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s42399-021-00755-0","article-title":"Hyper-oncotic vs. hypo-oncotic albumin solutions: a systematic review of clinical efficacy and safety","volume":"3","author":"Haynes","year":"2021","unstructured":"13. Haynes GR, Bassiri K. Hyper-oncotic vs. hypo-oncotic albumin solutions: a systematic review of clinical efficacy and safety. SN Compr Clin Med. 2021;3(5):1137-47.","journal-title":"SN Compr Clin Med"},{"issue":"6","key":"key20260703172348_B14","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/00000542-200606000-00018","article-title":"Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability","volume":"104","author":"Jacob","year":"2006","unstructured":"14. Jacob M, Bruegger D, Rehm M, Welsch U, Conzen P, Becker BF. Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology. 2006;104(6):1223-31.","journal-title":"Anesthesiology"},{"issue":"3","key":"key20260703172348_B15","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.CCM.0000114574.18641.5D","article-title":"Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury","volume":"32","author":"Quinlan","year":"2004","unstructured":"15. Quinlan GJ, Mumby S, Martin GS, Bernard GR, Gutteridge JM, Evans TW. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med. 2004;32(3):755-9.","journal-title":"Crit Care Med"},{"issue":"13","key":"key20260703172348_B16","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.febslet.2008.04.057","article-title":"The antioxidant properties of serum albumin","volume":"582","author":"Roche","year":"2008","unstructured":"16. Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008;582(13):1783-7.","journal-title":"FEBS Lett"},{"issue":"6","key":"key20260703172348_B17","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-014-0656-0","article-title":"The impact of hydroxyethyl starches in cardiac surgery: a meta-analysis","volume":"18","author":"Jacob","year":"2014","unstructured":"17. Jacob M, Fellahi JL, Chappell D, Kurz A. The impact of hydroxyethyl starches in cardiac surgery: a meta-analysis. Crit Care. 2014;18(6):656.","journal-title":"Crit Care"},{"issue":"1","key":"key20260703172348_B18","article-title":"The effect of human albumin administration on postoperative renal function following major surgery: a systematic review and meta-analysis","volume":"14","author":"Lee","year":"2024","unstructured":"18. Lee KS, Kim JE, Kang G, Won YJ, Choi YJ. The effect of human albumin administration on postoperative renal function following major surgery: a systematic review and meta-analysis. Sci Rep. 2024;14(1):16599. https:\/\/doi.org\/10.1038\/s41598-024-62495-0.","journal-title":"Sci Rep"},{"issue":"2","key":"key20260703172348_B19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bja.2023.11.009","article-title":"Intravenous albumin in cardiac and vascular surgery: a systematic review and meta-analysis","volume":"132","author":"Skubas","year":"2024","unstructured":"19. Skubas NJ, Callum J, Bathla A, Keshavarz H, Fergusson D, Wu B, et al.; International Collaboration for Transfusion Medicine Guidelines. Intravenous albumin in cardiac and vascular surgery: a systematic review and meta-analysis. Br J Anaesth. 2024;132(2):237-50.","journal-title":"Br J Anaesth"},{"issue":"2","key":"key20260703172348_B20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.chest.2024.02.049","article-title":"Use of Intravenous Albumin: A Guideline from the International Collaboration for Transfusion Medicine Guidelines","volume":"166","author":"Callum","year":"2024","unstructured":"20. Callum J, Skubas NJ, Bathla A, Keshavarz H, Clark EG, Rochwerg B, et al.; International Collaboration for Transfusion Medicine Guidelines Intravenous Albumin Guideline Group. Use of Intravenous Albumin: A Guideline from the International Collaboration for Transfusion Medicine Guidelines. Chest. 2024;166(2):321-38.","journal-title":"Chest"},{"issue":"7","key":"key20260703172348_B21","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00134-024-07488-3","article-title":"Twenty percent human albumin solution fluid bolus administration therapy in patients after cardiac surgery-II: a multicentre randomised controlled trial","volume":"50","author":"Wigmore","year":"2024","unstructured":"21. Wigmore GJ, Deane AM, Presneill JJ, Eastwood G, Serpa Neto A, Maiden MJ, et al.; HAS FLAIR-II investigators. Twenty percent human albumin solution fluid bolus administration therapy in patients after cardiac surgery-II: a multicentre randomised controlled trial. Intensive Care Med. 2024;50(7):1075-85.","journal-title":"Intensive Care Med"},{"issue":"8","key":"key20260703172348_B22","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jamasurg.2025.1683","article-title":"Postoperative 20% Albumin Infusion and Acute Kidney Injury in High-Risk Cardiac Surgery Patients: The ALBICS AKI Randomized Clinical Trial","volume":"160","author":"Shehabi","year":"2025","unstructured":"22. Shehabi Y, Balachandran M, Al-Bassam W, Bailey M, Bellomo R, Bihari S, et al.; ALBICS AKI Study Investigators. Postoperative 20% Albumin Infusion and Acute Kidney Injury in High-Risk Cardiac Surgery Patients: The ALBICS AKI Randomized Clinical Trial. JAMA Surg. 2025;160(8):835-44.","journal-title":"JAMA Surg"},{"issue":"8","key":"key20260703172348_B23","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s12630-021-01991-7","article-title":"Albumin in adult cardiac surgery: a narrative review","volume":"68","author":"Hanley","year":"2021","unstructured":"23. Hanley C, Callum J, Karkouti K, Bartoszko J. Albumin in adult cardiac surgery: a narrative review. Can J Anesth. 2021;68(8):1197-213.","journal-title":"Can J Anesth"},{"issue":"22","key":"key20260703172348_B24","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10225285","article-title":"Cardiac surgery associated AKI prevention strategies and medical treatment for CSA-AKI","volume":"10","author":"Ostermann","year":"2021","unstructured":"24. Ostermann M, Kunst G, Baker E, Weerapolchai K, Lumlertgul N. Cardiac surgery associated AKI prevention strategies and medical treatment for CSA-AKI. J Clin Med. 2021;10(22):5285.","journal-title":"J Clin Med"},{"key":"key20260703172348_B25","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","unstructured":"25. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"key20260703172348_B26","author":"Covidence systematic review software","unstructured":"26. Covidence systematic review software. Veritas Health Innovation. [cited 2024 May 8]. Available from: https:\/\/www.covidence.org\/","journal-title":"Veritas Health Innovation"},{"key":"key20260703172348_B27","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","unstructured":"27. Sterne JA, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019 Aug;366:l4898.","journal-title":"BMJ"},{"issue":"1","key":"key20260703172348_B28","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","unstructured":"28. Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14(1):135.","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"key20260703172348_B29","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/jrsm.1475","article-title":"On weakly informative prior distributions for the heterogeneity parameter in Bayesian random-effects meta-analysis","volume":"12","author":"R\u00f6ver","year":"2021","unstructured":"29. R\u00f6ver C, Bender R, Dias S, Schmid CH, Schmidli H, Sturtz S, et al. On weakly informative prior distributions for the heterogeneity parameter in Bayesian random-effects meta-analysis. Res Synth Methods. 2021;12(4):448-74.","journal-title":"Res Synth Methods"},{"issue":"6","key":"key20260703172348_B30","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/sim.6381","article-title":"Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis","volume":"34","author":"Turner","year":"2015","unstructured":"30. Turner RM, Jackson D, Wei Y, Thompson SG, Higgins JP. Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis. Stat Med. 2015;34(6):984-98.","journal-title":"Stat Med"},{"issue":"5","key":"key20260703172348_B31","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1164\/rccm.202006-2381CP","article-title":"Using Bayesian methods to augment the interpretation of critical care trials. An overview of theory and example reanalysis of the alveolar recruitment for acute respiratory distress syndrome trial","volume":"203","author":"Zampieri","year":"2021","unstructured":"31. Zampieri FG, Casey JD, Shankar-Hari M, Harrell FE Jr, Harhay MO. Using Bayesian methods to augment the interpretation of critical care trials. An overview of theory and example reanalysis of the alveolar recruitment for acute respiratory distress syndrome trial. Am J Respir Crit Care Med. 2021;203(5):543-52.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"key20260703172348_B32","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/ALN.0000000000001051","article-title":"Effect of exogenous albumin on the incidence of postoperative acute kidney injury in patients undergoing off-pump coronary artery bypass surgery with a preoperative albumin level of less than 4.0 g\/dl","volume":"124","author":"Lee","year":"2016","unstructured":"32. Lee EH, Kim WJ, Kim JY, Chin JH, Choi DK, Sim JY, et al. Effect of exogenous albumin on the incidence of postoperative acute kidney injury in patients undergoing off-pump coronary artery bypass surgery with a preoperative albumin level of less than 4.0 g\/dl. Anesthesiology. 2016;124(5):1001-11.","journal-title":"Anesthesiology"},{"issue":"2","key":"key20260703172348_B33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/bja\/aet348","article-title":"Comparison of the effects of albumin 5%, hydroxyethyl starch 130\/0.4 6%, and Ringer's lactate on blood loss and coagulation after cardiac surgery","volume":"112","author":"Skhirtladze","year":"2014","unstructured":"33. Skhirtladze K, Base EM, Lassnigg A, Kaider A, Linke S, Dworschak M, et al. Comparison of the effects of albumin 5%, hydroxyethyl starch 130\/0.4 6%, and Ringer's lactate on blood loss and coagulation after cardiac surgery. Br J Anaesth. 2014;112(2):255-64.","journal-title":"Br J Anaesth"},{"key":"key20260703172348_B34","author":"R Core Team","unstructured":"34. R Core Team. R: A Language and Environment for Statistical Computing. [Software]. R Foundation for Statistical Computing. [accessed May 8, 2024]. Available from: https:\/\/www.r-project.org\/","journal-title":"R: A Language and Environment for Statistical Computing"},{"issue":"6","key":"key20260703172348_B35","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v093.i06","article-title":"Bayesian Random-Effects Meta-Analysis Using the bayesmeta R Package","volume":"93","author":"R\u00f6ver","year":"2020","unstructured":"35. R\u00f6ver C. Bayesian Random-Effects Meta-Analysis Using the bayesmeta R Package. J Stat Softw. 2020;93(6):151.","journal-title":"J Stat Softw"},{"key":"key20260703172348_B36","author":"McMaster University and Evidence Prime","unstructured":"36. McMaster University and Evidence Prime. GRADEpro GDT: GRADEpro Guideline Development Tool. [cited 2024 May 8]. Available from: https:\/\/gdt.gradepro.org\/app\/","journal-title":"GRADEpro GDT: GRADEpro Guideline Development Tool"},{"issue":"1","key":"key20260703172348_B37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.15562\/ism.v13i1.1043","article-title":"Comparison of albumin 4%, gelatine, and ringer lactate as volume expander post-resuscitative phase on cardiac output and lactate serum after coronary arterial bypass grafting (CABG) on-pump: single-center randomized prospective study","volume":"13","author":"Adriane","year":"2022","unstructured":"37. Adriane P, Dewi NL, Ardiyan A. Comparison of albumin 4%, gelatine, and ringer lactate as volume expander post-resuscitative phase on cardiac output and lactate serum after coronary arterial bypass grafting (CABG) on-pump: single-center randomized prospective study. Intisari Sains Medis. 2022;13(1):102-8.","journal-title":"Intisari Sains Medis"},{"issue":"6","key":"key20260703172348_B38","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0003-4975(10)60907-1","article-title":"Clinical comparison of hetastarch and albumin in postoperative cardiac patients","volume":"34","author":"Diehl","year":"1982","unstructured":"38. Diehl JT, Lester JL 3rd, Cosgrove DM. Clinical comparison of hetastarch and albumin in postoperative cardiac patients. Ann Thorac Surg. 1982;34(6):674-9.","journal-title":"Ann Thorac Surg"},{"issue":"9","key":"key20260703172348_B39","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/anae.14994","article-title":"Effect of 6% hydroxyethyl starch 130\/0.4 on kidney and haemostatic function in cardiac surgical patients: a randomised controlled trial","volume":"75","author":"Duncan","year":"2020","unstructured":"39. Duncan AE, Jia Y, Soltesz E, Leung S, Yilmaz HO, Mao G, et al. Effect of 6% hydroxyethyl starch 130\/0.4 on kidney and haemostatic function in cardiac surgical patients: a randomised controlled trial. Anaesthesia. 2020;75(9):1180-90.","journal-title":"Anaesthesia"},{"issue":"2","key":"key20260703172348_B40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/imi.0000000000000123","article-title":"Systemic inflammatory response during cardiac surgery: a pilot study","volume":"10","author":"Fitzgerald","year":"2015","unstructured":"40. Fitzgerald DC, Holmes SD, St Onge JR, Ioanou C, Martin LM, Ad N. Systemic inflammatory response during cardiac surgery: a pilot study. Innovations (Phila). 2015;10(2):125-32.","journal-title":"Innovations (Phila)"},{"issue":"1","key":"key20260703172348_B41","first-page":"18","article-title":"A comparison of 3.5% dextran 40 and 4% albumin used as volume expansion solutions following heart surgery. Effects on the hemodynamic parameters and the oncotic colloidal pressure","volume":"41","author":"George","year":"1993","unstructured":"41. George M, Griffith N, Lehot JJ, Durand PG, Estanove S. [A comparison of 3.5% dextran 40 and 4% albumin used as volume expansion solutions following heart surgery. Effects on the hemodynamic parameters and the oncotic colloidal pressure]. Cah Anesthesiol. 1993;41(1):18-22.","journal-title":"Cah Anesthesiol"},{"issue":"1","key":"key20260703172348_B42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0003-4975(10)60707-2","article-title":"Hydroxyethyl starch versus albumin for colloid infusion following cardiopulmonary bypass in patients undergoing myocardial revascularization","volume":"37","author":"Kirklin","year":"1984","unstructured":"42. Kirklin JK, Lell WA, Kouchoukos NT. Hydroxyethyl starch versus albumin for colloid infusion following cardiopulmonary bypass in patients undergoing myocardial revascularization. Ann Thorac Surg. 1984;37(1):40-6.","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"key20260703172348_B43","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0022-5223(19)34525-8","article-title":"A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations","volume":"97","author":"London","year":"1989","unstructured":"43. London MJ, Ho JS, Triedman JK, Verrier ED, Levin J, Merrick SH, et al. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg. 1989;97(5):785-97.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"7","key":"key20260703172348_B44","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/bjs.1800750717","article-title":"Hydroxyethyl starch: an alternative to plasma for postoperative volume expansion after cardiac surgery","volume":"75","author":"Munsch","year":"1988","unstructured":"44. Munsch CM, MacIntyre E, Machin SJ, Mackie IJ, Treasure T. Hydroxyethyl starch: an alternative to plasma for postoperative volume expansion after cardiac surgery. Br J Surg. 1988 l;75(7):675-8.","journal-title":"Br J Surg"},{"issue":"3","key":"key20260703172348_B45","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/jama.2022.10461","article-title":"Effect of 4% albumin solution vs ringer acetate on major adverse events in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized clinical trial","volume":"328","author":"Pesonen","year":"2022","unstructured":"45. Pesonen E, Vlasov H, Suojaranta R, Hiippala S, Schramko A, Wilkman E, et al. Effect of 4% albumin solution vs ringer acetate on major adverse events in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized clinical trial. JAMA. 2022;328(3):251-8.","journal-title":"JAMA"},{"issue":"5","key":"key20260703172348_B46","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1399-6576.1995.tb04146.x","article-title":"Fluid balance and pulmonary functions during and after coronary artery bypass surgery: ringer's acetate compared with dextran, polygeline, or albumin","volume":"39","author":"T\u00f8ll\u00f8fsrud","year":"1995","unstructured":"46. T\u00f8ll\u00f8fsrud S, Svennevig JL, Breivik H, Kongsgaard U, Ozer M, Hysing E, et al. Fluid balance and pulmonary functions during and after coronary artery bypass surgery: ringer's acetate compared with dextran, polygeline, or albumin. Acta Anaesthesiol Scand. 1995;39(5):671-7.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"4","key":"key20260703172348_B47","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1055\/s-2007-1012012","article-title":"Fluid resuscitation with Haemaccel vs. human albumin following coronary artery bypass grafting","volume":"44","author":"Wahba","year":"1996","unstructured":"47. Wahba A, Sendtner E, Birnbaum DE. Fluid resuscitation with Haemaccel vs. human albumin following coronary artery bypass grafting. Thorac Cardiovasc Surg. 1996;44(4):178-82.","journal-title":"Thorac Cardiovasc Surg"},{"issue":"2","key":"key20260703172348_B48","article-title":"PRISMA 2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis","volume":"18","author":"Haddaway","year":"2022","unstructured":"48. Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. PRISMA 2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis. Campbell Sysr Rev. 2022;18(2):e1230.","journal-title":"Campbell Sysr Rev"},{"key":"key20260703172348_B49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/B978-0-12-374432-6.00033-6","volume-title":"Transfusion Medicine and Hemostasis","author":"Winkler","year":"2009","unstructured":"49. Winkler AM, Shaz BH. Albumin and related products. In: Hillyer CD, Shaz BH, Zimring JC, Abshire TC, editors. Transfusion Medicine and Hemostasis. Academic Press; 2009. Chapter 33, p. 185-91."},{"issue":"1","key":"key20260703172348_B50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","unstructured":"50. McGuinness LA, Higgins JP. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12(1):55-61.","journal-title":"Res Synth Methods"},{"issue":"6","key":"key20260703172348_B51","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.athoracsur.2021.03.043","article-title":"STS adult cardiac surgery database: 2021 update on outcomes, quality, and research","volume":"111","author":"Bowdish","year":"2021","unstructured":"51. Bowdish ME, D'Agostino RS, Thourani VH, Schwann TA, Krohn C, Desai N, et al. STS adult cardiac surgery database: 2021 update on outcomes, quality, and research. Ann Thorac Surg. 2021;111(6):1770-80.","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"key20260703172348_B52","doi-asserted-by":"crossref","DOI":"10.1186\/s12893-021-01340-x","article-title":"The comparison of albumin and 6% hydroxyethyl starches (130\/0.4) in cardiac surgery: a meta-analysis of randomized controlled clinical trials","volume":"21","author":"Wei","year":"2021","unstructured":"52. Wei L, Li D, Sun L. The comparison of albumin and 6% hydroxyethyl starches (130\/0.4) in cardiac surgery: a meta-analysis of randomized controlled clinical trials. BMC Surg. 2021;21(1):342.","journal-title":"BMC Surg"},{"issue":"3","key":"key20260703172348_B53","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/17511437241259437","article-title":"The efficacy, safety and effectiveness of hyperoncotic albumin solutions in patients with sepsis: A systematic review and meta-analysis","volume":"25","author":"Bannard-Smith","year":"2024","unstructured":"53. Bannard-Smith J, Elrakhawy M, Norman G, Owen R, Felton T, Dark P. The efficacy, safety and effectiveness of hyperoncotic albumin solutions in patients with sepsis: A systematic review and meta-analysis. J Intensive Care Soc. 2024;25(3):308-18.","journal-title":"J Intensive Care Soc"},{"issue":"8","key":"key20260703172348_B54","article-title":"Colloids versus crystalloids for fluid resuscitation in critically ill people","volume":"8","author":"Lewis","year":"2018","unstructured":"54. Lewis SR, Pritchard MW, Evans DJ, Butler AR, Alderson P, Smith AF, et al. Colloids versus crystalloids for fluid resuscitation in critically ill people. Cochrane Database Syst Rev. 2018;8(8):CD000567.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"key20260703172348_B55","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1053\/j.jvca.2023.10.008","article-title":"Safety and Efficacy of Albumin for Pump Priming in Cardiac Surgery: A Meta-Analysis","volume":"38","author":"Yin","year":"2024","unstructured":"55. Yin J, Sun M, Zeng Y, Cai M, Liu H, Jin Y. Safety and Efficacy of Albumin for Pump Priming in Cardiac Surgery: A Meta-Analysis. J Cardiothorac Vasc Anesth. 2024;38(2):517-25.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"1","key":"key20260703172348_B56","doi-asserted-by":"crossref","DOI":"10.1186\/s13019-020-01133-y","article-title":"The influence of postoperative albumin levels on the outcome of cardiac surgery","volume":"15","author":"Berbel-Franco","year":"2020","unstructured":"56. Berbel-Franco D, Lopez-Delgado JC, Putzu A, Esteve F, Torrado H, Farrero E, et al. The influence of postoperative albumin levels on the outcome of cardiac surgery. J Cardiothorac Surg. 2020;15(1):78.","journal-title":"J Cardiothorac Surg"},{"issue":"9","key":"key20260703172348_B57","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1007\/s00134-012-2599-8","article-title":"Preoperative hypoalbuminemia is a major risk factor for acute kidney injury following off-pump coronary artery bypass surgery","volume":"38","author":"Lee","year":"2012","unstructured":"57. Lee EH, Baek SH, Chin JH, Choi DK, Son HJ, Kim WJ, et al. Preoperative hypoalbuminemia is a major risk factor for acute kidney injury following off-pump coronary artery bypass surgery. Intensive Care Med. 2012;38(9):1478-86.","journal-title":"Intensive Care Med"},{"issue":"5","key":"key20260703172348_B58","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/anae.14577","article-title":"Postoperative microcirculatory perfusion and endothelial glycocalyx shedding following cardiac surgery with cardiopulmonary bypass","volume":"74","author":"Dekker","year":"2019","unstructured":"58. Dekker NA, Veerhoek D, Koning NJ, van Leeuwen AL, Elbers PW, van den Brom CE, et al. Postoperative microcirculatory perfusion and endothelial glycocalyx shedding following cardiac surgery with cardiopulmonary bypass. Anaesthesia. 2019;74(5):609-18.","journal-title":"Anaesthesia"},{"issue":"7","key":"key20260703172348_B59","doi-asserted-by":"crossref","first-page":"H967","DOI":"10.1152\/ajpheart.00397.2014","article-title":"Systemic microvascular shunting through hyperdynamic capillaries after acute physiological disturbances following cardiopulmonary bypass","volume":"307","author":"Koning","year":"2014","unstructured":"59. Koning NJ, Simon LE, Asfar P, Baufreton C, Boer C. Systemic microvascular shunting through hyperdynamic capillaries after acute physiological disturbances following cardiopulmonary bypass. Am J Physiol Heart Circ Physiol. 2014;307(7):H967-75.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"key20260703172348_B60","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.15173","article-title":"Renal injury in cardiorenal syndrome type 1 is mediated by albumin","volume":"10","author":"Funahashi","year":"2022","unstructured":"60. Funahashi Y, Ikeda M, Wakasaki R, Chowdhury S, Groat T, Zeppenfeld D, et al. Renal injury in cardiorenal syndrome type 1 is mediated by albumin. Physiol Rep. 2022;10(3):e15173.","journal-title":"Physiol Rep"},{"issue":"2","key":"key20260703172348_B61","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2246996","article-title":"Management of priming fluids in cardiopulmonary bypass for adult cardiac surgery: network meta-analysis","volume":"55","author":"Xian-Yu","year":"2023","unstructured":"61. Xian-Yu CY, Xu JB, Ma YT, Deng NJ, Tao YT, Li HJ, et al. Management of priming fluids in cardiopulmonary bypass for adult cardiac surgery: network meta-analysis. Ann Med. 2023;55(2):2246996.","journal-title":"Ann Med"},{"issue":"1","key":"key20260703172348_B62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.aucc.2020.06.001","article-title":"An international comparison of the cost of fluid resuscitation therapies","volume":"34","author":"Taylor","year":"2021","unstructured":"62. Taylor C, Yang L, Finfer S, Machado FR, YouZhong A, Billot L, et al.; Fluid-TRIPS and Fluidos Investigators, The George Institute for Global Health, The ANZICS Clinical Trials Group, BRICNet, and the REVA Research Network. An international comparison of the cost of fluid resuscitation therapies. Aust Crit Care. 2021;34(1):23-32.","journal-title":"Aust Crit Care"},{"key":"key20260703172348_B63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2024.154761","article-title":"Patient-important upper gastrointestinal bleeding in the ICU: a mixed-methods study of patient and family perspectives","volume":"81","author":"Vanstone","year":"2024","unstructured":"63. Vanstone MG, Krewulak K, Taneja S, Swinton M, Fiest K, Burns KE, et al.; Canadian Critical Care Trials Group. Patient-important upper gastrointestinal bleeding in the ICU: a mixed-methods study of patient and family perspectives. J Crit Care. 2024;81:154761.","journal-title":"J Crit Care"},{"issue":"12","key":"key20260703172348_B64","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/phar.2195","article-title":"Cohort study of albumin versus lactated ringer's for postoperative cardiac surgery fluid resuscitation in the intensive care unit","volume":"38","author":"Fink","year":"2018","unstructured":"64. Fink RJ, Young A, Yanez ND, Hom M, Mai J, Treggiari M, et al. Cohort study of albumin versus lactated ringer's for postoperative cardiac surgery fluid resuscitation in the intensive care unit. Pharmacotherapy. 2018;38(12):1241-9.","journal-title":"Pharmacotherapy"},{"issue":"1","key":"key20260703172348_B65","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.athoracsur.2016.10.018","article-title":"Restricted albumin utilization is safe and cost effective in a cardiac surgery intensive care unit","volume":"104","author":"Rabin","year":"2017","unstructured":"65. Rabin J, Meyenburg T, Lowery AV, Rouse M, Gammie JS, Herr D. Restricted albumin utilization is safe and cost effective in a cardiac surgery intensive care unit. Ann Thorac Surg. 2017;104(1):42-8.","journal-title":"Ann Thorac Surg"},{"issue":"8","key":"key20260703172348_B66","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2403769","article-title":"A randomized trial of intravenous amino acids for kidney protection","volume":"391","author":"Landoni","year":"2024","unstructured":"66. Landoni G, Monaco F, Ti LK, Baiardo Redaelli M, Bradic N, Comis M, et al.; PROTECTION Study Group. A randomized trial of intravenous amino acids for kidney protection. N Engl J Med. 2024;391(8):687-98.","journal-title":"N Engl J Med"},{"issue":"17","key":"key20260703172348_B67","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1001\/jama.2024.20630","article-title":"Extracorporeal blood purification and acute kidney injury in cardiac surgery: the SIRAKI02 randomized clinical trial","volume":"332","author":"P\u00e9rez-Fern\u00e1ndez","year":"2024","unstructured":"67. P\u00e9rez-Fern\u00e1ndez X, Ulsamer A, C\u00e1mara-Rosell M, Sbraga F, Boza-Hern\u00e1ndez E, Moret-Ru\u00edz E, et al.; SIRAKI02 Study Group. Extracorporeal blood purification and acute kidney injury in cardiac surgery: the SIRAKI02 randomized clinical trial. JAMA. 2024;332(17):1446-54.","journal-title":"JAMA"}],"container-title":["Critical Care Science"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:24:00Z","timestamp":1783099440000},"score":1,"resource":{"primary":{"URL":"https:\/\/criticalcarescience.org\/article\/perioperative-albumin-versus-other-fluids-to-prevent-cardiac-surgery-associated-kidney-injury-a-systematic-review-and-meta-analysis-of-randomized-trials\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":67,"alternative-id":["10.62675\/2965-2774.20260353"],"URL":"https:\/\/doi.org\/10.62675\/2965-2774.20260353","relation":{},"ISSN":["2965-2774"],"issn-type":[{"value":"2965-2774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e20260353"}}